Joshua A. Dubland

1.0k total citations
17 papers, 792 citations indexed

About

Joshua A. Dubland is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Joshua A. Dubland has authored 17 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Joshua A. Dubland's work include Atherosclerosis and Cardiovascular Diseases (4 papers), Cholesterol and Lipid Metabolism (4 papers) and Neonatal Health and Biochemistry (3 papers). Joshua A. Dubland is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (4 papers), Cholesterol and Lipid Metabolism (4 papers) and Neonatal Health and Biochemistry (3 papers). Joshua A. Dubland collaborates with scholars based in Canada and United States. Joshua A. Dubland's co-authors include Gordon A. Francis, Sima Allahverdian, Michael A. Seidman, Ying Wang, Başak Şahin, Don D. Sin, Nicholas J. Leeper, Naniye Mallı Cetinbas, Charles J. Walsby and Michael I. Webb and has published in prestigious journals such as SHILAP Revista de lepidopterología, Arteriosclerosis Thrombosis and Vascular Biology and Tetrahedron.

In The Last Decade

Joshua A. Dubland

16 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua A. Dubland Canada 12 262 231 163 131 107 17 792
Chiara Ricci Italy 11 187 0.7× 180 0.8× 427 2.6× 130 1.0× 99 0.9× 18 751
Kenji Ohwaki Japan 18 341 1.3× 139 0.6× 122 0.7× 85 0.6× 78 0.7× 30 866
Yoko Yamagiwa Japan 17 404 1.5× 222 1.0× 239 1.5× 108 0.8× 146 1.4× 38 1.0k
Lu Zhou China 17 314 1.2× 78 0.3× 82 0.5× 108 0.8× 127 1.2× 50 683
Ivo Nnane United States 17 359 1.4× 186 0.8× 91 0.6× 91 0.7× 47 0.4× 46 1.0k
Kaori Endo‐Umeda Japan 14 231 0.9× 165 0.7× 195 1.2× 77 0.6× 68 0.6× 24 591
H. A. Dresel Germany 16 236 0.9× 177 0.8× 223 1.4× 61 0.5× 110 1.0× 28 794
Parvathy Sasikumar United Kingdom 15 252 1.0× 111 0.5× 93 0.6× 45 0.3× 28 0.3× 26 746
Yi‐Jen Liao Taiwan 19 385 1.5× 100 0.4× 74 0.5× 146 1.1× 222 2.1× 60 911
Kenji Kuwabara Japan 14 315 1.2× 96 0.4× 92 0.6× 52 0.4× 167 1.6× 23 938

Countries citing papers authored by Joshua A. Dubland

Since Specialization
Citations

This map shows the geographic impact of Joshua A. Dubland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua A. Dubland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua A. Dubland more than expected).

Fields of papers citing papers by Joshua A. Dubland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua A. Dubland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua A. Dubland. The network helps show where Joshua A. Dubland may publish in the future.

Co-authorship network of co-authors of Joshua A. Dubland

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua A. Dubland. A scholar is included among the top collaborators of Joshua A. Dubland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua A. Dubland. Joshua A. Dubland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Monteiro, Lauar de Brito, Armando Alcázar Magaña, Joshua A. Dubland, et al.. (2025). Inhibition of xanthine oxidoreductase with febuxostat, but not allopurinol, prevents inflammasome assembly and IL-1β release. Life Science Alliance. 8(8). e202403191–e202403191.
2.
Dubland, Joshua A., Graham Sinclair, Hilary Vallance, & Bojana Rakić. (2022). A simple method modification to increase separation of 2- and 3-hydroxyglutaric acid by GC–MS for clinical urine organic acids analysis. Clinical Biochemistry. 105-106. 81–86. 1 indexed citations
3.
Dubland, Joshua A., Bojana Rakić, Hilary Vallance, & Graham Sinclair. (2021). Analysis of 2-methylcitric acid, methylmalonic acid, and total homocysteine in dried blood spots by LC-MS/MS for application in the newborn screening laboratory: A dual derivatization approach. SHILAP Revista de lepidopterología. 20. 1–10. 9 indexed citations
4.
Li, Dailin, et al.. (2021). Interference of ketone bodies on laboratory creatinine measurement in children with DKA: a call for change in testing practices. Pediatric Nephrology. 37(6). 1347–1353. 9 indexed citations
5.
Dubland, Joshua A.. (2021). Editorial commentary: Role of inflammatory cytokines in genesis and treatment of atherosclerosis. Looking at foam cells through a different lens. Trends in Cardiovascular Medicine. 32(3). 143–145. 3 indexed citations
6.
7.
Dubland, Joshua A., Sima Allahverdian, Ying Wang, et al.. (2021). Low LAL (Lysosomal Acid Lipase) Expression by Smooth Muscle Cells Relative to Macrophages as a Mechanism for Arterial Foam Cell Formation. Arteriosclerosis Thrombosis and Vascular Biology. 41(6). e354–e368. 30 indexed citations
8.
Dubland, Joshua A., et al.. (2019). Pathways of smooth muscle foam cell formation in atherosclerosis. Current Opinion in Lipidology. 30(2). 117–124. 52 indexed citations
9.
Wang, Ying, Joshua A. Dubland, Sima Allahverdian, et al.. (2019). Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 39(5). 876–887. 242 indexed citations
10.
Dubland, Joshua A., Teddy Chan, Yongping Xu, et al.. (2018). LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo. Arteriosclerosis Thrombosis and Vascular Biology. 38(5). 1191–1201. 22 indexed citations
11.
Saeedi, Ramesh, Joshua A. Dubland, Masoud Yousefi, et al.. (2017). Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism. Annals of Hepatology. 16(2). 207–214. 11 indexed citations
12.
Levin, Adeera, Mila Tang, Nadia Zalunardo, et al.. (2017). Randomized Controlled Trial for the Effect of Vitamin D Supplementation on Vascular Stiffness in CKD. Clinical Journal of the American Society of Nephrology. 12(9). 1447–1460. 57 indexed citations
13.
Dubland, Joshua A. & Gordon A. Francis. (2016). So Much Cholesterol. Current Opinion in Lipidology. 27(2). 155–161. 69 indexed citations
14.
Dubland, Joshua A. & Gordon A. Francis. (2015). Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism. Frontiers in Cell and Developmental Biology. 3. 3–3. 106 indexed citations
15.
16.
Lai, Ping‐Shan, Joshua A. Dubland, Mohammed G. Sarwar, Michael G. Chudzinski, & Mark S. Taylor. (2011). Carbon–carbon bond-forming reactions of α-carbonyl carbocations: exploration of a reversed-polarity equivalent of enolate chemistry. Tetrahedron. 67(39). 7586–7592. 42 indexed citations
17.
Cetinbas, Naniye Mallı, Michael I. Webb, Joshua A. Dubland, & Charles J. Walsby. (2009). Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR. JBIC Journal of Biological Inorganic Chemistry. 15(2). 131–145. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Ricci Breakdown of academic impact, for papers by Kenji Ohwaki Breakdown of academic impact, for papers by Yoko Yamagiwa Breakdown of academic impact, for papers by Lu Zhou Breakdown of academic impact, for papers by Ivo Nnane Breakdown of academic impact, for papers by Kaori Endo‐Umeda Breakdown of academic impact, for papers by H. A. Dresel Breakdown of academic impact, for papers by Parvathy Sasikumar Breakdown of academic impact, for papers by Yi‐Jen Liao Breakdown of academic impact, for papers by Kenji Kuwabara
Rankless by CCL
2026